论文部分内容阅读
中、高度恶性非霍奇金淋巴瘤 (ＮＨＬ)采用常规联合化疗效果极差 ,近年来通过改变化疗药物并提高药物剂量治疗中高度ＮＨＬ,取得了良好的治疗效果 ;大剂量化疗的严重后果是骨髓抑制 ,造血细胞刺激因子的应用为大剂量化疗治疗恶性淋巴瘤提供了安全有效的保障。我们在ＣＨＯＰ方
The effect of conventional combined chemotherapy for moderately and highly malignant non-Hodgkin lymphoma (NHL) is extremely poor. In recent years, a good therapeutic effect has been achieved by altering chemotherapeutic agents and increasing drug doses to treat moderately high levels of NHL; serious consequences of high-dose chemotherapy are Myelosuppression and application of hematopoietic cell stimulating factors provide safe and effective protection for malignant lymphoma with high-dose chemotherapy. We are on the CHOP side